What was Adamis Pharma’s price range in the past 12 months?
Adamis Pharma lowest share price was $2.26 and its highest was $35.71 in the past 12 months.
What is Adamis Pharma’s market cap?
Currently, no data Available
When is Adamis Pharma’s upcoming earnings report date?
Adamis Pharma’s upcoming earnings report date is Aug 10, 2023 which is in 63 days.
How were Adamis Pharma’s earnings last quarter?
Adamis Pharma released its earnings results on May 15, 2023. The company reported -$4.2 earnings per share for the quarter, missing the consensus estimate of N/A by -$4.2.
Adamis Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Adamis Pharma have?
Currently, no data Available
What happened to Adamis Pharma’s price movement after its last earnings report?
Adamis Pharma reported an EPS of -$4.2 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Adamis Pharma?
Among the largest hedge funds holding Adamis Pharma’s share is Greenlight Capital Inc. It holds Adamis Pharma’s shares valued at N/A.
This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.